Last reviewed · How we verify
NCT07083557: VALD
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
trial testing Endothelial cell collection in Obesity and Obesity-related Medical Conditions in 100 participants. Currently enrolling.
1 July 2030
Quick facts
| Lead sponsor | Bettina Mittendorfer |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 January 2026 |
| Primary completion | 1 July 2030 |
| Estimated completion | 1 July 2030 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Endothelial cell collection
Conditions studied
- Obesity and Obesity-related Medical Conditions — all drugs for Obesity and Obesity-related Medical Conditions →
- Diabetes — all drugs for Diabetes →
- Atherosclerotic Disease — all drugs for Atherosclerotic Disease →
- Heart Failure — all drugs for Heart Failure →
Sponsor
Bettina Mittendorfer
Who can join
Adults 18 to 100, any sex, with Obesity and Obesity-related Medical Conditions or Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research study is to validate (check the accuracy of) laboratory assays, intravenous catheter insertion, and equipment or devices and their reproducibility, which is necessary to perform high quality research on chronic diseases, nutrition, and metabolism (the process by which a substance is handled in the body) at the University of Missouri. As technology changes and uses new testing methods, it is necessary to compare results from old tests, equipment and devices and new tests, equipment, or devices and the reproducibility of these measurements to make sure the results are accurate. Reproducibility means performing the same test more than once to see if the same results can be achieved each time. This study will look at the validation and reproducibility of tests and laboratory assays in participants who are healthy or affected by relevant endocrine, cardiometabolic, and musculoskeletal disorders.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07083557
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Endothelial cell collection
Trials testing the same drug.
- NCT02209636 — Phosphate Lowering in CKD Trial · Phase 4 · completed
Other recruiting trials for Obesity and Obesity-related Medical Conditions
Currently open trials in the same condition.
- NCT06924177 — UTSW NORC Pilot Spinal Cord Injury Dietary Program · NA · recruiting
- NCT07213245 — Metabolic Effects of Short-term Ultra-processed Food Intake (MEST-UPF) · NA · recruiting
- NCT06768827 — New Mechanisms of Obesity · NA · recruiting
- NCT06790225 — Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA) · NA · recruiting
- NCT06630663 — A Wearable Device and AI-Supported Diet and Exercise Intervention · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07083557 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bettina Mittendorfer
- Last refreshed: 14 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07083557.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing